Polymasc's medical soap opera
Article Abstract:
Polymasc is a biotechnology developer developed from work at the Royal Free Hospital School of Medicine, London, England. The company is 50% owned by its founders and the medical school, and could be very successful if its technology can be marketed. The technique being developed by Polymasc allows drugs to be retained for longer so that lower doses are needed. This could be useful for a number of conditions including cancer and gene therapy. The company's shares are seen as good value in Jan 1996.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Mushrooming
Article Abstract:
Xenova is a UK biotechnology company that seeks to develop drugs from natural chemicals, and the company has the biggest library of such chemicals worldwide. Xenova has set up alliances with major pharmaceutical companies such as Genentech and Warner Lambert, and the company will have royalties if compounds it identifies can be marketed. Xenova is also developing its own drugs from compounds which have the greatest potential and is developing two anti-cancer treatments and a thrombosis drug.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Phytopharm
Article Abstract:
Phytopharm is a biotechnology company which uses traditional remedies based on plants to develop drugs. The company develops remedies where some evidence is available of their effectiveness, and this helps reduce risks of failure. The company has signed an agreement with Pfizer which will fund development of an appetite suppressant using a herb from South Africa. The company's stock price have been affected by negative sentiment relating to the sector, but it is a relatively low risk firm.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Environmental cap setter. Contaminated food for thought. Employee benefits and property and casualty insurance remain top concerns for businesses in 2006
- Abstracts: Hercules begins to reveal its strength. Shift to renting. Moorfield buoyed up by innovative ideals
- Abstracts: Another twelve months of investment action. A chance to outperform. Investment tricks for 1996
- Abstracts: Sid goes European. Latin America rebounds. Plugging into multimedia